{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:26:19Z","timestamp":1780424779827,"version":"3.54.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,24]]},"DOI":"10.7759\/cureus.105799","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:40:22Z","timestamp":1774410022000},"source":"Crossref","is-referenced-by-count":1,"title":["The Role of Biotics in Rosacea: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Alondra L","family":"Avenda\u00f1o-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz","family":"Orozco-Covarrubias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marimar","family":"Saez-de-Ocariz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.0526","article-title":"Assessment of frequency of rosacea subtypes in patients with rosacea: a systematic review and meta-analysis","volume":"158","author":"Barakji YA","year":"2022","unstructured":"Barakji YA, R\u00f8nnstad AT, Christensen MO, et al.. Assessment of frequency of rosacea subtypes in patients with rosacea: a systematic review and meta-analysis. JAMA Dermatol. 2022, 158:617-25. 10.1001\/jamadermatol.2022.0526","journal-title":"JAMA Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16481","article-title":"Incidence and prevalence of rosacea: a systematic review and meta-analysis","volume":"179","author":"Gether L","year":"2018","unstructured":"Gether L, Overgaard LK, Egeberg A, Thyssen JP. Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol. 2018, 179:282-9. 10.1111\/bjd.16481","journal-title":"Br J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1323644","article-title":"Rosacea, microbiome and probiotics: the gut-skin axis","volume":"14","author":"S\u00e1nchez-Pellicer P","year":"2023","unstructured":"S\u00e1nchez-Pellicer P, Eguren-Michelena C, Garc\u00eda-Gav\u00edn J, et al.. Rosacea, microbiome and probiotics: the gut-skin axis. Front Microbiol. 2023, 14:1323644. 10.3389\/fmicb.2023.1323644","journal-title":"Front Microbiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00842-z","article-title":"The skin microbiome and its significance for dermatologists","volume":"25","author":"Whiting C","year":"2024","unstructured":"Whiting C, Abdel Azim S, Friedman A. The skin microbiome and its significance for dermatologists. Am J Clin Dermatol. 2024, 25:169-77. 10.1007\/s40257-023-00842-z","journal-title":"Am J Clin Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea","volume":"46","author":"Wilkin J","year":"2002","unstructured":"Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, Powell F. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2002, 46:584-7. 10.1067\/mjd.2002.120625","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.08.037","article-title":"Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee","volume":"78","author":"Gallo RL","year":"2018","unstructured":"Gallo RL, Granstein RD, Kang S, Mannis M, Steinhoff M, Tan J, Thiboutot D. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018, 78:148-55. 10.1016\/j.jaad.2017.08.037","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00595-7","article-title":"Rosacea: new concepts in classification and treatment","volume":"22","author":"van Zuuren EJ","year":"2021","unstructured":"van Zuuren EJ, Arents BW, van der Linden MM, Vermeulen S, Fedorowicz Z, Tan J. Rosacea: new concepts in classification and treatment. Am J Clin Dermatol. 2021, 22:457-65. 10.1007\/s40257-021-00595-7","journal-title":"Am J Clin Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2021.10.004","article-title":"Rosacea pathogenesis, common triggers, and dietary role: the cause, the trigger, and the positive effects of different foods","volume":"40","author":"Alia E","year":"2022","unstructured":"Alia E, Feng H. Rosacea pathogenesis, common triggers, and dietary role: the cause, the trigger, and the positive effects of different foods. Clin Dermatol. 2022, 40:122-7. 10.1016\/j.clindermatol.2021.10.004","journal-title":"Clin Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14030557","article-title":"Topical probiotics: more than a skin deep","volume":"14","author":"Habeebuddin M","year":"2022","unstructured":"Habeebuddin M, Karnati RK, Shiroorkar PN, Nagaraja S, Asdaq SM, Khalid Anwer M, Fattepur S. Topical probiotics: more than a skin deep. Pharmaceutics. 2022, 14:10.3390\/pharmaceutics14030557","journal-title":"Pharmaceutics"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i34.11950","article-title":"Extraintestinal manifestations of Helicobacter pylori: a concise review","volume":"20","author":"Wong F","year":"2014","unstructured":"Wong F, Rayner-Hartley E, Byrne MF. Extraintestinal manifestations of Helicobacter pylori: a concise review. World J Gastroenterol. 2014, 20:11950-61. 10.3748\/wjg.v20.i34.11950","journal-title":"World J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2018.03.012","article-title":"The microbiome in dermatology","volume":"36","author":"Musthaq S","year":"2018","unstructured":"Musthaq S, Mazuy A, Jakus J. The microbiome in dermatology. Clin Dermatol. 2018, 36:390-8. 10.1016\/j.clindermatol.2018.03.012","journal-title":"Clin Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14032","article-title":"The role of topical probiotics in skin conditions: a systematic review of animal and human studies and implications for future therapies","volume":"29","author":"Knackstedt R","year":"2020","unstructured":"Knackstedt R, Knackstedt T, Gatherwright J. The role of topical probiotics in skin conditions: a systematic review of animal and human studies and implications for future therapies. Exp Dermatol. 2020, 29:15-21. 10.1111\/exd.14032","journal-title":"Exp Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.m0922","article-title":"Supplement article: the role of epidermal barrier dysfunction and cutaneous microbiome dysbiosis in the pathogenesis and management of acne vulgaris and rosacea","volume":"21","author":"Marson J","year":"2022","unstructured":"Marson J, Bhatia N, Graber E, et al.. Supplement article: the role of epidermal barrier dysfunction and cutaneous microbiome dysbiosis in the pathogenesis and management of acne vulgaris and rosacea. J Drugs Dermatol. 2022, 21:SF3502915-SF35029114. 10.36849\/JDD.m0922","journal-title":"J Drugs Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12122667","article-title":"Characteristics of the stool, blood and skin microbiome in rosacea patients","volume":"12","author":"Joura MI","year":"2024","unstructured":"Joura MI, Jobb\u00e1gy A, Dunai ZA, et al.. Characteristics of the stool, blood and skin microbiome in rosacea patients. Microorganisms. 2024, 12:10.3390\/microorganisms12122667","journal-title":"Microorganisms"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-03433-y","article-title":"Exploring the association between skin microbiota and inflammatory skin diseases: a two-sample Mendelian randomization analysis","volume":"316","author":"Pan L","year":"2024","unstructured":"Pan L, Li C, Liang Z, Shi J. Exploring the association between skin microbiota and inflammatory skin diseases: a two-sample Mendelian randomization analysis. Arch Dermatol Res. 2024, 316:677. 10.1007\/s00403-024-03433-y","journal-title":"Arch Dermatol Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1427276","article-title":"Causal roles of skin and gut microbiota in skin appendage disorders suggested by genetic study","volume":"15","author":"Zhu Y","year":"2024","unstructured":"Zhu Y, Liu W, Wang M, Wang X, Wang S. Causal roles of skin and gut microbiota in skin appendage disorders suggested by genetic study. Front Immunol. 2024, 15:1427276. 10.3389\/fimmu.2024.1427276","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/srt.70035","article-title":"Skin microbiome and causal relationships in three dermatological diseases: evidence from Mendelian randomization and Bayesian weighting","volume":"30","author":"Li X","year":"2024","unstructured":"Li X, Chen S, Chen S, et al.. Skin microbiome and causal relationships in three dermatological diseases: evidence from Mendelian randomization and Bayesian weighting. Skin Res Technol. 2024, 30:e70035. 10.1111\/srt.70035","journal-title":"Skin Res Technol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00460-1","article-title":"Rosacea and the microbiome: a systematic review","volume":"11","author":"Daou H","year":"2021","unstructured":"Daou H, Paradiso M, Hennessy K, Seminario-Vidal L. Rosacea and the microbiome: a systematic review. Dermatol Ther (Heidelb). 2021, 11:1-12. 10.1007\/s13555-020-00460-1","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12121","article-title":"Rosacea under the microscope: characteristic histological findings","volume":"27","author":"Cribier B","year":"2013","unstructured":"Cribier B. Rosacea under the microscope: characteristic histological findings. J Eur Acad Dermatol Venereol. 2013, 27:1336-43. 10.1111\/jdv.12121","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17817","article-title":"Erythematotelangiectatic rosacea may be associated with a subclinical stage of demodicosis: a case-control study","volume":"181","author":"Forton F","year":"2019","unstructured":"Forton F, De Maertelaer V. Erythematotelangiectatic rosacea may be associated with a subclinical stage of demodicosis: a case-control study. Br J Dermatol. 2019, 181:818-25. 10.1111\/bjd.17817","journal-title":"Br J Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12030","article-title":"Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation","volume":"21","author":"Casas C","year":"2012","unstructured":"Casas C, Paul C, Lahfa M, et al.. Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation. Exp Dermatol. 2012, 21:906-10. 10.1111\/exd.12030","journal-title":"Exp Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1108661","article-title":"Role of the skin microbiota and intestinal microbiome in rosacea","volume":"14","author":"Zhu W","year":"2023","unstructured":"Zhu W, Hamblin MR, Wen X. Role of the skin microbiota and intestinal microbiome in rosacea. Front Microbiol. 2023, 14:1108661. 10.3389\/fmicb.2023.1108661","journal-title":"Front Microbiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.05.005","article-title":"Temperature regulates bacterial protein production: possible role in rosacea","volume":"50","author":"Dahl MV","year":"2004","unstructured":"Dahl MV, Ross AJ, Schlievert PM. Temperature regulates bacterial protein production: possible role in rosacea. J Am Acad Dermatol. 2004, 50:266-72. 10.1016\/j.jaad.2003.05.005","journal-title":"J Am Acad Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2001.00331.x","article-title":"Increased density of Demodex folliculorum and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosacea","volume":"15","author":"Georgala S","year":"2001","unstructured":"Georgala S, Katoulis AC, Kylafis GD, Koumantaki-Mathioudaki E, Georgala C, Aroni K. Increased density of Demodex folliculorum and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosacea. J Eur Acad Dermatol Venereol. 2001, 15:441-4. 10.1046\/j.1468-3083.2001.00331.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04310.x","article-title":"Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link","volume":"26","author":"Forton FM","year":"2012","unstructured":"Forton FM. Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link. J Eur Acad Dermatol Venereol. 2012, 26:19-28. 10.1111\/j.1468-3083.2011.04310.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16540","article-title":"Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosacea","volume":"179","author":"Lacey N","year":"2018","unstructured":"Lacey N, Russell-Hallinan A, Zouboulis CC, Powell FC. Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosacea. Br J Dermatol. 2018, 179:420-30. 10.1111\/bjd.16540","journal-title":"Br J Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13401","article-title":"Rosacea and the gastrointestinal system","volume":"61","author":"Searle T","year":"2020","unstructured":"Searle T, Ali FR, Carolides S, Al-Niaimi F. Rosacea and the gastrointestinal system. Australas J Dermatol. 2020, 61:307-11. 10.1111\/ajd.13401","journal-title":"Australas J Dermatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/12034754241229365","article-title":"Rosacea: pathogenesis and therapeutic correlates","volume":"28","author":"Geng RS","year":"2024","unstructured":"Geng RS, Bourkas AN, Mufti A, Sibbald RG. Rosacea: pathogenesis and therapeutic correlates. J Cutan Med Surg. 2024, 28:178-89. 10.1177\/12034754241229365","journal-title":"J Cutan Med Surg"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1292722","article-title":"Rosacea pathogenesis and therapeutics: current treatments and a look at future targets","volume":"10","author":"Fisher GW","year":"2023","unstructured":"Fisher GW, Travers JB, Rohan CA. Rosacea pathogenesis and therapeutics: current treatments and a look at future targets. Front Med (Lausanne). 2023, 10:1292722. 10.3389\/fmed.2023.1292722","journal-title":"Front Med (Lausanne)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2017.11.001","article-title":"Rosacea pathogenesis","volume":"36","author":"Ahn CS","year":"2018","unstructured":"Ahn CS, Huang WW. Rosacea pathogenesis. Dermatol Clin. 2018, 36:81-6. 10.1016\/j.det.2017.11.001","journal-title":"Dermatol Clin"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.0704a08","article-title":"Diet and rosacea: the role of dietary change in the management of rosacea","volume":"7","author":"Weiss E","year":"2017","unstructured":"Weiss E, Katta R. Diet and rosacea: the role of dietary change in the management of rosacea. Dermatol Pract Concept. 2017, 7:31-7. 10.5826\/dpc.0704a08","journal-title":"Dermatol Pract Concept"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1297240","article-title":"The associations between gut microbiota and inflammatory skin diseases: a bi-directional two-sample Mendelian randomization study","volume":"15","author":"Zhong Y","year":"2024","unstructured":"Zhong Y, Wang F, Meng X, Zhou L. The associations between gut microbiota and inflammatory skin diseases: a bi-directional two-sample Mendelian randomization study. Front Immunol. 2024, 15:1297240. 10.3389\/fimmu.2024.1297240","journal-title":"Front Immunol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2021.08.021","article-title":"The skin microbiome and the gut-skin axis","volume":"39","author":"Sinha S","year":"2021","unstructured":"Sinha S, Lin G, Ferenczi K. The skin microbiome and the gut-skin axis. Clin Dermatol. 2021, 39:829-39. 10.1016\/j.clindermatol.2021.08.021","journal-title":"Clin Dermatol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2096995","article-title":"Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases","volume":"14","author":"Mahmud MR","year":"2022","unstructured":"Mahmud MR, Akter S, Tamanna SK, et al.. Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases. Gut Microbes. 2022, 14:2096995. 10.1080\/19490976.2022.2096995","journal-title":"Gut Microbes"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14930","article-title":"Rosacea and gastrointestinal disorders: a population-based cohort study","volume":"176","author":"Egeberg A","year":"2017","unstructured":"Egeberg A, Weinstock LB, Thyssen EP, Gislason GH, Thyssen JP. Rosacea and gastrointestinal disorders: a population-based cohort study. Br J Dermatol. 2017, 176:100-6. 10.1111\/bjd.14930","journal-title":"Br J Dermatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.07.055","article-title":"Evidence-based update on rosacea comorbidities and their common physiologic pathways","volume":"78","author":"Holmes AD","year":"2018","unstructured":"Holmes AD, Spoendlin J, Chien AL, Baldwin H, Chang AL. Evidence-based update on rosacea comorbidities and their common physiologic pathways. J Am Acad Dermatol. 2018, 78:156-66. 10.1016\/j.jaad.2017.07.055","journal-title":"J Am Acad Dermatol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01624-x","article-title":"Rosacea, germs, and bowels: a review on gastrointestinal comorbidities and gut-skin axis of rosacea","volume":"38","author":"Wang FY","year":"2021","unstructured":"Wang FY, Chi CC. Rosacea, germs, and bowels: a review on gastrointestinal comorbidities and gut-skin axis of rosacea. Adv Ther. 2021, 38:1415-24. 10.1007\/s12325-021-01624-x","journal-title":"Adv Ther"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13398","article-title":"Rosacea and its association with enteral microbiota in Korean females","volume":"27","author":"Nam JH","year":"2018","unstructured":"Nam JH, Yun Y, Kim HS, et al.. Rosacea and its association with enteral microbiota in Korean females. Exp Dermatol. 2018, 27:37-42. 10.1111\/exd.13398","journal-title":"Exp Dermatol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14016","article-title":"Targeting the gut-skin axis-probiotics as new tools for skin disorder management?","volume":"28","author":"Sz\u00e1nt\u00f3 M","year":"2019","unstructured":"Sz\u00e1nt\u00f3 M, D\u00f3zsa A, Antal D, Szab\u00f3 K, Kem\u00e9ny L, Bai P. Targeting the gut-skin axis-probiotics as new tools for skin disorder management?. Exp Dermatol. 2019, 28:1210-8. 10.1111\/exd.14016","journal-title":"Exp Dermatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8111756","article-title":"Diversity and composition of the skin, blood and gut microbiome in rosacea-a systematic review of the literature","volume":"8","author":"Tutka K","year":"2020","unstructured":"Tutka K, \u017bychowska M, Reich A. Diversity and composition of the skin, blood and gut microbiome in rosacea-a systematic review of the literature. Microorganisms. 2020, 8:10.3390\/microorganisms8111756","journal-title":"Microorganisms"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2004.01461.x","article-title":"Remission of rosacea induced by reduction of gut transit time","volume":"29","author":"Kendall SN","year":"2004","unstructured":"Kendall SN. Remission of rosacea induced by reduction of gut transit time. Clin Exp Dermatol. 2004, 29:297-9. 10.1111\/j.1365-2230.2004.01461.x","journal-title":"Clin Exp Dermatol"},{"key":"ref42","article-title":"Vasoactive polypeptides in rosacea","author":"Snitsarenko OV","year":"1989","unstructured":"Snitsarenko OV. Vasoactive polypeptides in rosacea. Vestn Dermatol Venerol. 1989, 42-4.","journal-title":"Vestn Dermatol Venerol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2020.04.034","article-title":"An altered fecal microbial profiling in rosacea patients compared to matched controls","volume":"120","author":"Chen YJ","year":"2021","unstructured":"Chen YJ, Lee WH, Ho HJ, Tseng CH, Wu CY. An altered fecal microbial profiling in rosacea patients compared to matched controls. J Formos Med Assoc. 2021, 120:256-64. 10.1016\/j.jfma.2020.04.034","journal-title":"J Formos Med Assoc"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/life14050585","article-title":"Characteristics of gut microbiota in rosacea patients-a cross-sectional, controlled pilot study","volume":"14","author":"Guertler A","year":"2024","unstructured":"Guertler A, Hering P, Pac\u00edfico C, et al.. Characteristics of gut microbiota in rosacea patients-a cross-sectional, controlled pilot study. Life (Basel). 2024, 14:10.3390\/life14050585","journal-title":"Life (Basel)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.09.016","article-title":"Comorbidities in rosacea: a systematic review and update","volume":"78","author":"Haber R","year":"2018","unstructured":"Haber R, El Gemayel M. Comorbidities in rosacea: a systematic review and update. J Am Acad Dermatol. 2018, 78:786-92.e8. 10.1016\/j.jaad.2017.09.016","journal-title":"J Am Acad Dermatol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/bies.201600008","article-title":"The gut-skin axis in health and disease: a paradigm with therapeutic implications","volume":"38","author":"O'Neill CA","year":"2016","unstructured":"O'Neill CA, Monteleone G, McLaughlin JT, Paus R. The gut-skin axis in health and disease: a paradigm with therapeutic implications. Bioessays. 2016, 38:1167-76. 10.1002\/bies.201600008","journal-title":"Bioessays"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.72363","article-title":"Evaluation of Helicobacter pylori and small intestinal bacterial overgrowth in subjects with rosacea","volume":"16","author":"Nelson JM","year":"2024","unstructured":"Nelson JM, Rizzo JM, Greene RK, Fahlstrom K, Troost JP, Helfrich YR, Nakamura M. Evaluation of Helicobacter pylori and small intestinal bacterial overgrowth in subjects with rosacea. Cureus. 2024, 16:e72363. 10.7759\/cureus.72363","journal-title":"Cureus"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.08.028","article-title":"Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors","volume":"72","author":"Two AM","year":"2015","unstructured":"Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015, 72:749-58. 10.1016\/j.jaad.2014.08.028","journal-title":"J Am Acad Dermatol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(99)70493-7","article-title":"Helicobacter pylori eradication treatment reduces the severity of rosacea","volume":"40","author":"Uta\u015f S","year":"1999","unstructured":"Uta\u015f S, Ozbakir O, Turasan A, Uta\u015f C. Helicobacter pylori eradication treatment reduces the severity of rosacea. J Am Acad Dermatol. 1999, 40:433-5. 10.1016\/s0190-9622(99)70493-7","journal-title":"J Am Acad Dermatol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.6.659","article-title":"Effect of treatment of Helicobacter pylori infection on rosacea","volume":"135","author":"Bamford JT","year":"1999","unstructured":"Bamford JT, Tilden RL, Blankush JL, Gangeness DE. Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol. 1999, 135:659-63. 10.1001\/archderm.135.6.659","journal-title":"Arch Dermatol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2000.15.5.551","article-title":"Relationship between Helicobacter pylori and rosacea: it may be a myth","volume":"15","author":"Herr H","year":"2000","unstructured":"Herr H, You CH. Relationship between Helicobacter pylori and rosacea: it may be a myth. J Korean Med Sci. 2000, 15:551-4. 10.3346\/jkms.2000.15.5.551","journal-title":"J Korean Med Sci"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.02.054","article-title":"Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication","volume":"6","author":"Parodi A","year":"2008","unstructured":"Parodi A, Paolino S, Greco A, et al.. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol. 2008, 6:759-64. 10.1016\/j.cgh.2008.02.054","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14683","article-title":"The impact of clinical nutrition on inflammatory skin diseases","volume":"20","author":"G\u00fcrtler A","year":"2022","unstructured":"G\u00fcrtler A, Laurenz S. The impact of clinical nutrition on inflammatory skin diseases. J Dtsch Dermatol Ges. 2022, 20:185-202. 10.1111\/ddg.14683","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00866-1","article-title":"Skin microbiota analysis-inspired development of novel anti-infectives","volume":"8","author":"Liu Y","year":"2020","unstructured":"Liu Y, Liu Y, Du Z, et al.. Skin microbiota analysis-inspired development of novel anti-infectives. Microbiome. 2020, 8:85. 10.1186\/s40168-020-00866-1","journal-title":"Microbiome"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.01201-24","article-title":"Effect of combined probiotics and doxycycline therapy on the gut-skin axis in rosacea","volume":"9","author":"Yu J","year":"2024","unstructured":"Yu J, Duan Y, Zhang M, et al.. Effect of combined probiotics and doxycycline therapy on the gut-skin axis in rosacea. mSystems. 2024, 9:e0120124. 10.1128\/msystems.01201-24","journal-title":"mSystems"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18088","article-title":"Changing our microbiome: probiotics in dermatology","volume":"182","author":"Yu Y","year":"2020","unstructured":"Yu Y, Dunaway S, Champer J, Kim J, Alikhan A. Changing our microbiome: probiotics in dermatology. Br J Dermatol. 2020, 182:39-46. 10.1111\/bjd.18088","journal-title":"Br J Dermatol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.4.2553","article-title":"Lipoteichoic acid isolated from Lactobacillus plantarum inhibits lipopolysaccharide-induced TNF-alpha production in THP-1 cells and endotoxin shock in mice","volume":"180","author":"Kim HG","year":"2008","unstructured":"Kim HG, Kim NR, Gim MG, et al.. Lipoteichoic acid isolated from Lactobacillus plantarum inhibits lipopolysaccharide-induced TNF-alpha production in THP-1 cells and endotoxin shock in mice. J Immunol. 2008, 180:2553-61. 10.4049\/jimmunol.180.4.2553","journal-title":"J Immunol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.14309\/00000434-201810001-00216","article-title":"Gut-skin connection: role of intestinal biome in rosacea","volume":"113","author":"Buianova I","year":"2018","unstructured":"Buianova I, Girnyk G, Senyshyn N, Hepburn IS. Gut-skin connection: role of intestinal biome in rosacea. Am J Gastroenterol. 2018, 113:S126. 10.14309\/00000434-201810001-00216","journal-title":"Am J Gastroenterol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12355","article-title":"A case of scalp rosacea treated with low dose doxycycline and probiotic therapy and literature review on therapeutic options","volume":"29","author":"Fortuna MC","year":"2016","unstructured":"Fortuna MC, Garelli V, Pranteda G, Romaniello F, Cardone M, Carlesimo M, Rossi A. A case of scalp rosacea treated with low dose doxycycline and probiotic therapy and literature review on therapeutic options. Dermatol Ther. 2016, 29:249-51. 10.1111\/dth.12355","journal-title":"Dermatol Ther"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i23.5415","article-title":"Intestinal-borne dermatoses significantly improved by oral application of Escherichia coli Nissle 1917","volume":"22","author":"Manzhalii E","year":"2016","unstructured":"Manzhalii E, Hornuss D, Stremmel W. Intestinal-borne dermatoses significantly improved by oral application of Escherichia coli Nissle 1917. World J Gastroenterol. 2016, 22:5415-21. 10.3748\/wjg.v22.i23.5415","journal-title":"World J Gastroenterol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1039\/d4fo03083d","article-title":"Probiotics suppress LL37 generated rosacea-like skin inflammation by modulating the TLR2\/MyD88\/NF-\u03baB signaling pathway","volume":"15","author":"Qi X","year":"2024","unstructured":"Qi X, Xiao Y, Zhang X, et al.. Probiotics suppress LL37 generated rosacea-like skin inflammation by modulating the TLR2\/MyD88\/NF-\u03baB signaling pathway. Food Funct. 2024, 15:8916-34. 10.1039\/d4fo03083d","journal-title":"Food Funct"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S391893","article-title":"A randomized, controlled clinical trial of a dermocosmetic containing Vichy volcanic mineralizing water and probiotic fractions in subjects with rosacea associated with erythema and sensitive skin and wearing protective masks","volume":"16","author":"Berardesca E","year":"2023","unstructured":"Berardesca E, Bonfigli A, Cartigliani C, Kerob D, Tan J. A randomized, controlled clinical trial of a dermocosmetic containing Vichy volcanic mineralizing water and probiotic fractions in subjects with rosacea associated with erythema and sensitive skin and wearing protective masks. Clin Cosmet Investig Dermatol. 2023, 16:71-7. 10.2147\/CCID.S391893","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7110550","article-title":"The skin and gut microbiome and its role in common dermatologic conditions","volume":"7","author":"Ellis SR","year":"2019","unstructured":"Ellis SR, Nguyen M, Vaughn AR, Notay M, Burney WA, Sandhu S, Sivamani RK. The skin and gut microbiome and its role in common dermatologic conditions. Microorganisms. 2019, 7:10.3390\/microorganisms7110550","journal-title":"Microorganisms"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1080\/27697061.2023.2232021","article-title":"Oral postbiotics as a therapeutic strategy for atopic dermatitis: a systematic review of randomized controlled trials","volume":"43","author":"Lima M","year":"2024","unstructured":"Lima M, Paulino LC. Oral postbiotics as a therapeutic strategy for atopic dermatitis: a systematic review of randomized controlled trials. J Am Nutr Assoc. 2024, 43:139-46. 10.1080\/27697061.2023.2232021","journal-title":"J Am Nutr Assoc"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2015.3943","article-title":"Synbiotics for prevention and treatment of atopic dermatitis: a meta-analysis of randomized clinical trials","volume":"170","author":"Chang YS","year":"2016","unstructured":"Chang YS, Trivedi MK, Jha A, Lin YF, Dimaano L, Garc\u00eda-Romero MT. Synbiotics for prevention and treatment of atopic dermatitis: a meta-analysis of randomized clinical trials. JAMA Pediatr. 2016, 170:236-42. 10.1001\/jamapediatrics.2015.3943","journal-title":"JAMA Pediatr"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.2165\/11531420-000000000-00000","article-title":"Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial","volume":"11","author":"Gerasimov SV","year":"2010","unstructured":"Gerasimov SV, Vasjuta VV, Myhovych OO, Bondarchuk LI. Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial. Am J Clin Dermatol. 2010, 11:351-61. 10.2165\/11531420-000000000-00000","journal-title":"Am J Clin Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/414253-the-role-of-biotics-in-rosacea-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:40:25Z","timestamp":1774410025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/414253-the-role-of-biotics-in-rosacea-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":66,"URL":"https:\/\/doi.org\/10.7759\/cureus.105799","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,24]]}}}